J&J beats profit estimates on pharmaceutical unit strength

Johnson & Johnson on Tuesday
reported fourth-quarter profit above Wall Street expectations,
helped by demand for its blockbuster psoriasis treatment Stelara
and strength in its medical device unit.
...

Related Keywords

Bengaluru ,Karnataka ,India ,United States ,Amgen Wezlana ,Arun Koyyur ,Bhanvi Satija ,Sriparna Roy ,Reuters ,Wall Street ,Markets ,